BNET Industries
Market Cap:$15.0M
Last Fiscal Year Sales:$28.6M
- Public
Contact Information
No. 2, Jing You Road
Kunming National Economy &
Technology Developing District 00000
0086-871-7282628
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009
News & Analysis
Filter by
china shenghuo pharmaceutical holdings inc. - All News and Analysis
China Shenghuo Reports Large Loss on Higher Revenues
Seeking Alpha
- 2009-05-18
ChinaBio Today submits: China Shenghuo Pharmaceutical Holdings (NYSE Amex Equities: KUN) declared that revenues rose 23% in the first quarter of 2008 to $6.8 million. The numbers raised cash flow to $890,000, but the company reported a net operating loss of $2.9 million, much higher than the $850,000 loss...
China Shenghuo's Revenues Can't Keep Up with Expenses
Seeking Alpha
- 2008-12-10
ChinaBio Today submits: China Shenghuo Pharmaceutical Holdings KUN has resumed trading on the NYSE Alternext US exchange. In early action, the price of its shares was cut in half, dropping 98 cents (52%) to $.91. The company’s stock was suspended from trading in late August because China...
China Biotech Week in Review: Earnings Turn Negative
Seeking Alpha
- 2008-08-24
ChinaBio Today submits: Earnings reports for China biomedical companies continued to be released during the past five days, though their pace dropped markedly from the week earlier. And the tone changed as well, turning more negative. In all, three companies reported, and Lotus Pharma [LTUS.OB] produced the most...
China Shenghuo Pharma to Restate Financial Results, Faces Potential De-listing from AMEX
Seeking Alpha
- 2008-08-21
ChinaBio Today submits: China Shenghuo Pharmaceutical Holdings, Inc. KUN will restate its financial reports from the past twelve months, saying that the company has discovered errors in sales commission advances and trade receivables. The Audit Committee and an independent counsel will review Shenghuo’s internal controls and the personnel who...
- 1
| Volume | 3,100 |
| Shares Outstanding | 19.6M |
| Market Cap | 15.0M |
| Year High | 1.75 |
| Year Low | 0.16 |
| Earnings Per Share | -0.37 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about HALO
-
Momenta Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about MNTA
-
Emergent BioSolutions Inc. Q3 2009 Earnings Call Transcript
on Nov 05, 2009about EBS
-
Targacept, Inc. Q3 2009 Earnings Call Transcript
on Nov 05, 2009about TRGT
-
Nabi Biopharmaceuticals Q3 2009 Earnings Call Transcript
on Nov 05, 2009about NABI
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Best Selling Drugs Will Soon be Biologics, But Not Owned by Biotechs 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
